Is orally inhaled dihydroergotamine (DHE) equivalent in efficacy in migraine to intravenous DHE?

Peer Tfelt-Hansen

doi:10.1111/head.12269

Is orally inhaled dihydroergotamine (DHE) equivalent in efficacy in migraine to intravenous DHE?

2 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Headache
Vol/bind	54
Udgave nummer	2
Sider (fra-til)	383
ISSN	0017-8748
DOI	https://doi.org/10.1111/head.12269
Status	Udgivet - feb. 2014

Adgang til dokumentet

10.1111/head.12269

Citationsformater

@article{75873c8bd23942d5b39a9993bd43d599,

title = "Is orally inhaled dihydroergotamine (DHE) equivalent in efficacy in migraine to intravenous DHE?",

keywords = "Administration, Inhalation, Administration, Intravenous, Administration, Oral, Dihydroergotamine, Humans, Migraine Disorders, Treatment Outcome",

author = "Peer Tfelt-Hansen",

year = "2014",

month = feb,

doi = "10.1111/head.12269",

language = "English",

volume = "54",

pages = "383",

journal = "Headache",

issn = "0017-8748",